Hepatitis C virus infection: Newer paradigms
HCV infection
Keywords:
Cirrhosis, hepatitis C, prevention, transmission, treatmentAbstract
Infections caused by hepatitis C virus (HCV) lead to persistent infection in most of the times and may cause fibrosis of liver, cirrhosis and hepatocellular carcinoma. At present, there is no vaccine available for prevention or treatment of it. With the development of newer and effective anti viral drugs, most of the infections are curable. But a proportion of infections may progress to cirrhosis of liver /or hepatocelllar carcinoma in spite of being cured from the infection. So, early diagnosis of HCV infections and treatment with effective antiviral drugs is required for prevention of end stage liver disease.
References
Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29:74-81.
Radha K Dhiman. Chronic viral hepatitis. In: Munjal YP, editor. API Medicine Text book, 10 th ed., Vol. 14. New Delhi: Jaypee Publishers; 2015. p. 1178-80.
Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol 2014;61(1 suppl);S58-68.
CDC. Testing for HCV infection: An update of guidance for clinicians and laboratorians. MMWR 2013;62(18).
Wander GS, Pareek KK. Physician′s role in eradicating hepatitis C. In: Milind NY, editor. Vol 26. New Delhi: Jaypee Publishers; 2016. p. 1224-32.
AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 2015;62:932-954.
Downloads
Published
How to Cite
Issue
Section
Downloads
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.